Hong Kong
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 8.96 B
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
2 |
USD 5.81 B
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
3 |
USD 5.22 B
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
4 |
USD 2.96 B
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
5 |
USD 2.50 B
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
6 |
USD 1.53 B
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
7 |
USD 1.28 B
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
8 |
USD 806.48 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
9 |
USD 571.87 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
10 |
USD 410.14 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
11 |
USD 370.09 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
12 |
USD 326.61 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
13 |
USD 254.17 M
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
14 |
USD 234.07 M
|
Dec. 31, 2023 | USD 0.26 | -2.87% |
|
Hong Kong |
|
15 |
USD 75.79 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Total Assets is Sino Biopharmaceutical Limited (HKSE: 1177.HK) at USD 8.96 B.
The Biotechnology company in Hong Kong with the lowest Total Assets is Sirnaomics Ltd. (HKSE: 2257.HK) at USD 75.79 M.
The top 10 Biotechnology companies in Hong Kong by Total Assets are Sino Biopharmaceutical Limited, BeiGene, Ltd., China Traditional Chinese Medicine Holdings Co. Limited, The United Laboratories International Holdings Limited, China Medical System Holdings Limited, SSY Group Limited, HUTCHMED (China) Limited, Guangdong Hybribio Biotech Co.,Ltd., Frontage Holdings Corporation and OrbusNeich Medical Group Holdings Limited.
The bottom 10 Biotechnology companies in Hong Kong by Total Assets are Sirnaomics Ltd., KuangChi Science Limited, Prenetics Global Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Lee's Pharmaceutical Holdings Limited, OrbusNeich Medical Group Holdings Limited, Frontage Holdings Corporation, Guangdong Hybribio Biotech Co.,Ltd., HUTCHMED (China) Limited and SSY Group Limited.